Video

Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipeline

Author(s):

Kassi Jackson
Conferences|ASCRS

Riad Sherif, MD, CEO of Oculis, gives a company update on clinical trials for products in DME, ocular surgery, and more; plus, growing products in glaucoma treatments, team and financing updates.

Related Videos
Related Content
4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform
December 20th 2024

4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Regeneron announces aflibercept 8mg injection meets primary endpoint in phase 3 QUASAR trial in patients with retinal vein occlusion
December 17th 2024

Regeneron announces aflibercept 8mg injection meets primary endpoint in phase 3 QUASAR trial in patients with retinal vein occlusion

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Specular microscopy: A practical guide for the assessment of corneal endothelial health and device selection
December 17th 2024

Specular microscopy: A practical guide for the assessment of corneal endothelial health and device selection

The human impact of geographic atrophy: Survey examines experiences and perceptions of patients living with GA
December 17th 2024

The human impact of geographic atrophy: Survey examines experiences and perceptions of patients living with GA

© 2024 MJH Life Sciences

All rights reserved.